Los Angeles Capital Management
HOOK

Los Angeles Capital Management’s HOOKIPA Pharma HOOK Stock Holding History

Los Angeles Capital Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,059
Closed -$298K – 1429
2021
Q3 		$298K Buy
5,059
+1,316
+35% +$95.4K ﹤0.01% 1310
2021
Q2 		$343K Buy
+3,743
New +$499K ﹤0.01% 1343

Other funds holding HOOK

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Los Angeles Capital Management's HOOK Position: Q4 2021 in Review

Los Angeles Capital Management sold out of HOOKIPA Pharma (HOOK) in Q4 2021, closing a stake of 5,059 shares — an estimated $298K sold.

Los Angeles Capital Management first reported a position in HOOK in Q2 2021 and held it in 2 quarters. The position peaked at $343K in Q2 2021. 72 funds tracked by Wall St. Rank hold HOOK as of Q4 2021.

  • Los Angeles Capital Management reported no remaining HOOKIPA Pharma position as of Q4 2021 after selling out during the quarter.
  • Los Angeles Capital Management sold 5,059 HOOKIPA Pharma shares in Q4 2021, an estimated $298K.
  • Los Angeles Capital Management first reported a position in HOOKIPA Pharma in Q2 2021 and held it in 2 quarters.
  • Los Angeles Capital Management's HOOKIPA Pharma position peaked at $343K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2021.

Based on Los Angeles Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.